17 Feb, 2023
Neonatal intensive care units (NICUs) are essential facilities for preterm and sick newborns. Unfortunately, NICUs are also exposed to infectious disease outbreaks that may put these tiny patients at risk.
To address this pressing issue, a multi-disciplinary group of experts will host a webinar titled “Protecting our tiniest patients: Strategies for managing NICU outbreaks” on Thursday, 9 March 2023, from 17:00 to 18:30 CET. The event will bring together neonatologists, neonatal nurses, infection prevention and control specialists and other healthcare professionals working in NICUs, linked through the NeoIPC Clinical Practice Network (CPN).
The preliminary agenda for the webinar includes:
The webinar will be led by topic experts:
This webinar promises to be an informative and engaging event that will discuss strategies for managing NICU outbreaks. Participants can expect to gain practical insights from the experts and connect with peers from different sectors and countries. Don’t miss this opportunity to improve your skills in managing neonatal outbreaks!
If you are already part of the NeoIPC Clinical Practice Network, please sign up through the link you received by e-mail.
If you are NOT part of the Clinical Practice Network but would like to attend the webinar, please fill in the NeoIPC CPN Registration Form. We will be in touch with a Zoom link to connect to the webinar on 9 March.
Please note that this event is open to NeoIPC Clinical Practice Network members, which comprises of healthcare professionals working in neonatal units worldwide. You don’t need to be involved in other NeoIPC activities to be part of the CPN. Learn more about the CPN and check out the resources available to its members.
NeoIPC is a project funded by the European Union’s Horizon 2020 research and innovation programme under grant agreement No 965328. NeoIPC’s aim is to establish innovative approaches for optimal infection prevention of resistant bacteria in NICUs by integrating research, implementation science and surveillance. Penta is the sponsor of the NeoIPC trial. Learn more about NeoIPC: neoipc.org